Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3865Neoplasms 2990Prostatic Neoplasms 1754Colorectal Neoplasms 1431Lung Neoplasms 1331Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Hepatocellular 632Carcinoma, Non-Small-Cell Lung 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 486Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 376Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Melanoma 323Multiple Myeloma 322Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 280

Interventions

Dexmedetomidine 2Saline Solution 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × Dexmedetomidine × Clear all
NCT05291364 2023-08-01

Dexmedetomidine in Splanchnic Nerve Neurolysis

Minia University

Phase NA Completed
40 enrolled

Dexmedetomidine

NCT04771637 2021-11-30

Effect of Dexmedetomidine on Perioperative Internal Environment and Rehabilitation of Patients Undergoing Gastrointestinal Malignant Tumor Resection

Yangzhou University

Phase NA Completed
140 enrolled

Dexmedetomidine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡